雅虎香港 搜尋

登入

搜尋結果

  1. pdf.hres.ca › dpd_pm › 00025395VAXIGRIP

    The type and amount of viral antigens contained in VAXIGRIP® conform to the current requirements of the World Health Organization (WHO). (1) The strains for the 2014 – 2015 season are: A/California/7/2009 (H1N1)pdm09-like strain, A/Texas/50/2012 (H3N2)-like strain and B/Massachusetts/2/2012-like strain.

    • 145KB
    • 23

  2. www.chp.gov.hk › tc › features衞生防護中心 - 季節性流感及肺炎球菌疫苗接種資訊 - Centre for ...

    季節性流感疫苗成分. 院舍防疫注射計劃在2015/16年度提供的疫苗包括以下成分： - 類甲型/加利福利亞/ 7/ 2009 (H1N1)pdm09病毒. - 類甲型/瑞士/9715293/2013 (H3N2) 病毒. - 類乙型/布吉/3073/2013病毒. - 類乙型/布利斯本/60/2008病毒. 院舍防疫注射計劃2015/16採用的是滅活流感疫苗。 建議劑量. 9歲或以上人士，每年都要接種一劑季節性流感疫苗。 為確保對季節性流感產生足夠的免疫力，凡9歲以下從未接種過季節性流感疫苗的兒童，建議應接種兩劑季節性流感疫苗，而兩劑疫苗的接種時間應至少相隔四個星期。 在2014/15年度或以前曾接種季節性流感疫苗的9歲以下兒童，在2015/16年度只需接種一劑疫苗。

  3. www.ncbi.nlm.nih.gov › pmc › articlesAn Advisory Committee Statement: Addendum to the 2010-2011 ...

    2011年9月9日 · NACI’s recommendations for the 2010-2011 season relate to use of four vaccines authorized in Canada that are formulated for intramuscular use: Fluviral ® (GlaxoSmithKline), Vaxigrip ® (Sanofi Pasteur), Agriflu ® (Novartis) and Influvac ® (Abbott).

  4. www.ncbi.nlm.nih.gov › pmc › articles4. A Novel Quadrivalent Inactivated Influenza Vaccine: ...

    2018年3月8日 · This review describes the results obtained from seven phase III clinical trials evaluating the immunogenicity, safety, and lot-to-lot consistency of a new quadrivalent split-virion influenza vaccine (Vaxigrip Tetra ®) formulated by adding a second B strain to the already licensed TIV.

  5. pubmed.ncbi.nlm.nih.gov › 29157068Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

    VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®).

  6. www.sanofi.com › assets › countriesPROFESSIONAL INFORMATION FOR VAXIGRIP TETRA - Sanofi

    VAXIGRIP TETRA is indicated for the prevention of influenza disease caused by the two influenza. virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age. and older,

  7. www.nature.com › articles › s41573/019/0056-xNext-generation influenza vaccines: opportunities and ...

    New influenza viruses have precipitated pandem-ics several times over the past 100 years, specifically in 1918, 1957, 1968 and 2009 (reF.4). The threat of the re- emergence of old pandemic...